期刊文献+

慢性肾功能不全病人中的氧化应激现象观察 被引量:8

下载PDF
导出
摘要 目的 :慢性肾功能衰竭 (慢性肾衰 )病人中普遍存在氧化应激状态 ,而氧化应激是慢性肾衰病人心血管病高发生率的重要原因。本文研究不同阶段慢性肾功能不全患者中丙二醛 (MDA )和谷胱甘肽过氧化物酶(GSHPx)变化。方法 :测定 110例慢性肾衰患者血清MDA、GSHPx的变化。结果 :慢性肾衰患者血清MDA随肾小球滤过率 (GFR)下降而升高 ,GSHPx水平随GFR下降而下降 ,而且各阶段比较差异有显著性。结论 :血清MDA、GSHPx的变化是反映慢性肾功能不全程度的较好指标 ,并可能对预测和预防动脉粥样硬化性心血管疾病发生有帮助。
作者 武强 刘郑荣
出处 《实用医学杂志》 CAS 2004年第10期1160-1161,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献6

  • 1中华医学会肾脏病分会透析移植登记工作组,钱家麒,张伟明,徐筱琪.1999年度全国透析移植登记报告[J].中华肾脏病杂志,2001,17(2):77-78. 被引量:441
  • 2余月明,侯凡凡,张训,刘俊,胡敏燕,杨凌,许顶立.慢性肾功能衰竭患者的高同型半胱氨酸血症[J].中华肾脏病杂志,2002,18(1):34-37. 被引量:45
  • 3Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32(Suppl 3):112- 119
  • 4Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition,inflammation and athersclerosis in chronic renal failure. Kidney Int, 1999, 55(5):1899-1911
  • 5Amann K, Ritz C, Adamczak M, et al. Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant ,2003,18(4) :631 - 640
  • 6Annu KM, Zilmer M, Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: Impact on cardiovascular disease. Kidney Int Suppl, 2003, (84) :s50 - 53

二级参考文献13

  • 1Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem, 1994, 40:873-881.
  • 2Jacobsen DW. Cardiovascular disorders (risk assessment) . Clin Chem, 1993, 65: 367R-373R.
  • 3Yeun JY. The role of homocysteine in end - stage renal disease.Seminars in Dialysis, 1998, 11: 95-101.
  • 4Nygard O, Norderhaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 1997, 337: 230-236.
  • 5Bostom AG, Lathrop L. Hyperhomocysteinemia in end- stage renal disease: prevalence, etiology, and potential relationship to artherosclerotic outcomes. Kidney Int, 1997, 52: 10-20.
  • 6Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998,32 Suppl 3: 112-119.
  • 7Yu HH, Joubran R, Asmi M, et al. Agreement among four homocysteine assays and results in patients with coronaryatherosclerosis and controls. Clin Chem, 2000, 46: 258-264.
  • 8Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron, 1995, 70: 62-67.
  • 9Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephron, 1999, 10: 891-900.
  • 10Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation, 1998, 97: 138-141.

共引文献484

同被引文献123

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部